We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joseph Lim

Joseph K Lim MD

Professor of Medicine; Director, Yale Viral Hepatitis Program, Section of Digestive Diseases/Yale Liver Center, Yale University School of Medicine, New Haven, Connecticut

Dr. Lim is a Professor of Medicine in the Section of Digestive Diseases at Yale University, where he serves as Director of the Yale Viral Hepatitis Program. He is a graduate of the Feinberg School of Medicine at Northwestern University (Chicago, Illinois, USA), and completed training in Internal Medicine at Yale University (New Haven, Connecticut, USA), and Gastroenterology and Hepatology at Stanford University (Palo Alto, California, USA). In his role at the Yale Liver Center, he directs an active clinical trials program evaluating novel investigational agents for hepatitis B, hepatitis C, and NASH. He serves on the national EPIC Gastroenterology Specialty Steering Board (Chair), and the steering committee of HCV-TARGET, a large multinational prospective observational cohort study evaluating HCV outcomes. He has held numerous leadership roles for the AASLD, AGA, and the ACG, and has served as Section Editor of JAMA, Senior Associate Editor of Journal of Clinical Gastroenterology, Editor-in-Chief of BMJ Open Gastroenterology, and on the editorial boards of JAMA, Gastrointestinal Endoscopy, and Hepatology.